Stéphane Oudard
Inserm(FR)Université Paris Cité(FR)Assistance Publique – Hôpitaux de Paris(FR)Hôpital Européen Georges-Pompidou(FR)Hôpital Européen(FR)Paris Cardiovascular Research Center(FR)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Prostate Cancer Treatment and Research, Cancer Immunotherapy and Biomarkers, Renal and related cancers, Cancer Genomics and Diagnostics
Most-Cited Works
- → Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma(2007)5,732 cited
- → Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer(2004)5,695 cited
- → Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma(2007)4,772 cited
- → Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial(2010)3,265 cited
- → Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial(2008)3,002 cited
- → Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma(2009)2,185 cited